Journal rankings · indicator year 2023
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2023
Infectious Diseases journal rankings 2023
259 ranked journals · Subfield in Medicine
Infectious Diseases has 259 ranked journals in 2023. The median journal has an OJR of 0.64, below the world average of 1.00, up 0.03 on 2022; Q1 starts at OJR 1.08. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and MMWR Morbidity and Mortality Weekly Report.
Ranks and citation indicators: 2023. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2020–2022, the window the 2023 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
Show all 42 subfields
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
259 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2022. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2020–2022, the window the 2023 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2020–2022 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2014 to 2023. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 13.12Q1 | 33.51 19.42 down from 2022 | 3,234 | 31% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 9.00Q1 | 21.91 8.98 down from 2022 | 100 | 100% | — | ||
3MMWR Morbidity and Mortality Weekly ReportOACenters for Disease Control and Prevention · United States | 7.04Q1 | 24.12 11.40 down from 2022 | 938 | 100% | — | ||
4The Lancet Infectious DiseasesElsevier BV · Netherlands | 4.45Q1 | 16.17 10.73 down from 2022 | 1,190 | 58% | $7,280 | ||
5The Lancet Global HealthOAElsevier BV · Netherlands | 4.02Q1 | 9.16 5.09 down from 2022 | 978 | 100% | $6,680 | ||
6PLoS MedicineOAPublic Library of Science · United States | 3.67Q1 | 12.77 1.29 down from 2022 | 871 | 100% | $6,460 | ||
7The Lancet Regional Health - EuropeOAElsevier BV · United Kingdom | 3.49Q1 | 9.56 6.06 down from 2022 | 485 | 100% | $4,930 | ||
8Annals of Internal MedicineAmerican College of Physicians · United States | 2.96Q1 | 7.27 6.17 down from 2022 | 1,215 | 16% | — | ||
9EClinicalMedicineOAElsevier BV · Netherlands | 2.93Q1 | 10.57 3.26 down from 2022 | 1,468 | 100% | $5,780 | ||
10EurosurveillanceOAEuropean Centre for Disease Prevention and Control · Sweden | 2.92Q1 | 10.56 10.01 down from 2022 | 639 | 100% | — | ||
11The Lancet MicrobeOAElsevier BV · United Kingdom | 2.71Q1 | 10.46 6.81 down from 2022 | 389 | 100% | $7,280 | ||
12Emerging Microbes & InfectionsOATaylor & Francis · United Kingdom | 2.44Q1 | 7.97 7.05 down from 2022 | 833 | 100% | $2,643 | ||
13Cellular Molecular and Biomedical ReportsOAPublisher not listed | 2.24Q1 | 6.51 7.23 down from 2022 | 47 | 100% | — | ||
14JMIR Public Health and SurveillanceOAJMIR Publications · Canada | 2.17Q1 | 4.72 5.31 down from 2022 | 664 | 100% | $2,800 | ||
15npj VaccinesOANature Portfolio · United Kingdom | 2.13Q1 | 7.89 2.70 down from 2022 | 424 | 100% | $3,890 | ||
16Clinical Infectious DiseasesOxford University Press · United States | 2.00Q1 | 7.26 3.62 down from 2022 | 3,639 | 85% | $4,763 | ||
17Clinical Microbiology and InfectionElsevier BV · United Kingdom | 1.99Q1 | 7.98 4.14 down from 2022 | 1,218 | 100% | $3,780 | ||
18Communications MedicineOANature Portfolio · United Kingdom | 1.99Q1 | 5.99 0.39 down from 2022 | 217 | 100% | $3,690 | ||
19Reviews in Medical VirologyWiley · United Kingdom | 1.91Q1 | 9.83 3.28 down from 2022 | 296 | 47% | $4,880 | ||
20Journal of Infection and Public HealthOAElsevier BV · Netherlands | 1.80Q1 | 5.88 4.33 down from 2022 | 742 | 100% | $2,310 | ||
21Antiviral ResearchElsevier BV · Netherlands | 1.79Q1 | 4.72 4.32 down from 2022 | 511 | 62% | $4,160 | ||
22Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 1.78Q1 | 5.70 3.66 down from 2022 | 1,727 | 100% | — | ||
23PLoS PathogensOAPublic Library of Science · United States | 1.76Q1 | 6.04 1.46 down from 2022 | 2,138 | 100% | $3,043 | ||
24Journal of Medical VirologyWiley · United States | 1.71Q1 | 6.41 6.61 down from 2022 | 2,695 | 63% | $4,730 | ||
25The Lancet HIVElsevier BV · Netherlands | 1.70Q1 | 7.22 2.92 down from 2022 | 383 | 53% | $7,280 | ||
26Virus EvolutionOAUniversity of Oxford · United Kingdom | 1.67Q1 | 5.43 2.27 down from 2022 | 327 | 100% | $3,304 | ||
27VirulenceOATaylor & Francis · United States | 1.64Q1 | 6.27 0.94 up from 2022 | 458 | 100% | $2,557 | ||
28VaccinesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.59Q1 | 6.11 3.00 down from 2022 | 4,548 | 100% | $3,258 | ||
29InfectionSpringer Science+Business Media · Germany | 1.59Q1 | 5.78 2.68 down from 2022 | 545 | 82% | $4,790 | ||
30Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.59Q1 | 5.80 2.83 down from 2022 | 934 | 100% | — | ||
31International Journal of Infectious DiseasesOAElsevier BV · Netherlands | 1.57Q1 | 5.32 4.75 down from 2022 | 2,586 | 100% | $2,900 | ||
32The Lancet Regional Health - Southeast AsiaOAPublisher not listed | 1.55Q1 | 3.85no 2022 value | 117 | 100% | $2,250 | — | |
33Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 1.53Q1 | 5.83 0.21 down from 2022 | 100 | 57% | $5,090 | ||
34Virology JournalOABioMed Central · United Kingdom | 1.49Q1 | 4.88 1.02 down from 2022 | 653 | 100% | $3,290 | ||
35Antimicrobial Resistance and Infection ControlOABioMed Central · United Kingdom | 1.48Q1 | 6.00 0.60 down from 2022 | 523 | 100% | $3,290 | ||
36The Journal of Infectious DiseasesOxford University Press · United States | 1.47Q1 | 5.04 1.53 down from 2022 | 1,815 | 90% | $4,763 | ||
37Current HIV/AIDS ReportsSpringer Science+Business Media · United States | 1.44Q1 | 5.43 0.04 up from 2022 | 165 | 62% | $4,190 | ||
38Journal of InfectionOAElsevier BV · United Kingdom | 1.40Q1 | 4.67 6.95 down from 2022 | 1,387 | 71% | $4,030 | ||
39Current Clinical Microbiology ReportsSpringer Science+Business Media · Germany | 1.37Q1 | 4.63 1.90 down from 2022 | 42 | 57% | $4,790 | ||
40Pathogens and ImmunityOACase Western Reserve University · United States | 1.36Q1 | 5.62 2.94 down from 2022 | 49 | 100% | — | ||
41Journal of Microbiology Immunology and InfectionOAElsevier BV · Hong Kong SAR China | 1.33Q1 | 3.44 4.15 down from 2022 | 436 | 100% | $2,000 | ||
42Expert Review of Anti-infective TherapyTaylor & Francis · United Kingdom | 1.33Q1 | 4.68 2.11 down from 2022 | 385 | 39% | — | ||
43PathogensOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.32Q1 | 3.97 0.38 down from 2022 | 4,292 | 100% | $2,654 | ||
44Microbiology SpectrumOAAmerican Society for Microbiology · United States | 1.31Q1 | 4.17 0.09 up from 2022 | 2,599 | 100% | $2,500 | ||
45Journal of Epidemiology and Global HealthOAElsevier BV · Netherlands | 1.31Q1 | 4.26 0.80 down from 2022 | 173 | 100% | $2,690 | ||
46Infectious Diseases and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.30Q1 | 5.56 0.63 down from 2022 | 425 | 100% | $7,400 | ||
47VirusesOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.28Q1 | 4.37 1.04 down from 2022 | 6,892 | 100% | $3,137 | ||
48Journal of General VirologyMicrobiology Society · United Kingdom | 1.27Q1 | 4.27 0.24 down from 2022 | 399 | 80% | — | ||
49Current Opinion in HIV and AIDSLippincott Williams & Wilkins · United Kingdom | 1.22Q1 | 4.56 0.47 up from 2022 | 124 | 55% | — | ||
50MycopathologiaSpringer Science+Business Media · Netherlands | 1.22Q1 | 4.45 2.95 down from 2022 | 232 | 29% | $4,190 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery993
- Pulmonary and Respiratory Medicine367
- Public Health, Environmental and Occupational Health313
- Cardiology and Cardiovascular Medicine293
- Infectious Diseases259
- Oncology245
- Epidemiology199
- Neurology174
- Physiology161
- Radiology, Nuclear Medicine and Imaging161
- Endocrinology, Diabetes and Metabolism159
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine124
- Ophthalmology105
- Pediatrics, Perinatology and Child Health99
- Dermatology97
- Obstetrics and Gynecology90
- Hematology84
- Rheumatology67
- Nephrology65
- Reproductive Medicine56
- Complementary and alternative medicine54
- Pharmacology52
- Emergency Medicine44
- Geriatrics and Gerontology38
- Rehabilitation35
- Otorhinolaryngology34
- Hepatology32
- Pathology and Forensic Medicine29
- Immunology and Allergy25
- Critical Care and Intensive Care Medicine22
- Genetics22
- Anesthesiology and Pain Medicine14
- Urology12
- Gastroenterology8
- Internal Medicine6
- Health Informatics5
- Transplantation3
- Family Practice2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2023. Corpus-wide, 88.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
52 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2020–2022, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2023. Publication window: 2020–2022. How these summaries are calculated
- Ranked journals
- 259
- Window papers (baseline)
- 162,915 +124.0% from indicator year 2020
- Median OJR
- 0.64 -19.9% from indicator year 2020
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2020–2022 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.